Related references
Note: Only part of the references are listed.Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation
Josephina Sampson et al.
EMBO REPORTS (2021)
Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines
Keisuke Taniguchi et al.
SCIENTIFIC REPORTS (2021)
Tubulin acetylation enhances lung cancer resistance to paclitaxel-induced cell death through Mcl-1 stabilization
Onsurang Wattanathamsan et al.
CELL DEATH DISCOVERY (2021)
EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7
Laura O'Regan et al.
JOURNAL OF CELL SCIENCE (2020)
Effects of α-tubulin acetylation on microtubule structure and stability
Lisa Eshun-Wilson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Mitotic phosphorylation by NEK6 and NEK7 reduces the microtubule affinity of EML4 to promote chromosome congression
Rozita Adib et al.
SCIENCE SIGNALING (2019)
Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map
Jennifer Huynh et al.
NATURE REVIEWS CANCER (2019)
The emerging treatment landscape of targeted therapy in non-small-cell lung cancer
Min Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
EML4-ALK fusion variant V3 is a high-risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK(+) non-small cell lung cancer
Petros Christopoulos et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer
Jessica J. Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer
C. G. Woo et al.
ANNALS OF ONCOLOGY (2017)
EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients
Sarah R. Sabir et al.
CANCERS (2017)
EML proteins in microtubule regulation and human disease
Andrew M. Fry et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors
Guolin Zhang et al.
SCIENCE SIGNALING (2016)
Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors
Guolin Zhang et al.
SCIENCE SIGNALING (2016)
Microtubule association of EML proteins and the EML4-ALK variant 3 oncoprotein require an N-terminal trimerization domain
Mark W. Richards et al.
BIOCHEMICAL JOURNAL (2015)
RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK-positive lung cancer
Gorjan Hrustanovic et al.
NATURE MEDICINE (2015)
Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes
Laurence Froidevaux-Klipfel et al.
ONCOTARGET (2015)
α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration
Amanda E. Boggs et al.
CANCER RESEARCH (2015)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain
Mark W. Richards et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
αTAT1 is the major α-tubulin acetyltransferase in mice
Nereo Kalebic et al.
NATURE COMMUNICATIONS (2013)
Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
Johannes M. Heuckmann et al.
CLINICAL CANCER RESEARCH (2012)
Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions
Carsten Janke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Inhibition of ALK, PI3K/MEK, and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion Oncogene
Zhao Chen et al.
CANCER RESEARCH (2010)
ALK (Anaplastic Lymphoma Kinase) expression in DRG neurons and its involvement in neuron-Schwann cells interaction
Joffrey Degoutin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
STAT3-Stathmin Interactions Control Microtubule Dynamics in Migrating T-cells
Navin K. Verma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Echinoderm microtubule-associated protein like protein 4, a member of the echinoderm microtubule-associated protein family, stabilizes microtubules
S. H. Houtman et al.
NEUROSCIENCE (2007)
Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
DCH Ng et al.
JOURNAL OF CELL BIOLOGY (2006)
Share Paper
